Dr. Hollander is a Professor of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine and Director of the Autism and Obsessive Compulsive Spectrum Program, and the Anxiety and Depression Program, at Montefiore Medical Center and the Albert Einstein College of Medicine. Previously he served as the Esther and Joseph Klingenstein Professor and Chair of Psychiatry at the Mount Sinai School of Medicine and was Director of the Seaver and NY Autism Center of Excellence in New York City. Before then he served as Associate Professor of Clinical Psychiatry at the Columbia University College of Physicians and Surgeons in New York.
Dr. Hollander received his B.A. from Brandeis University (1978), and his M.D. from SUNY Downstate Medical College, Brooklyn (1982). He completed his internship in Internal Medicine at Mt. Sinai Hospital (1983), residency and chief resident in psychiatry at Mt Sinai School of Medicine (1986), and his NIMH research fellowship at Columbia University College of Physicians and Surgeons (1988). He has served as an Associate Professor of Clinical Psychiatry at Columbia University College of Physicians and Surgeons, and as the Esther and Joseph Klingenstein Professor and Chair of Psychiatry at the Mount Sinai School of Medicine.
Dr. Hollander has served as the principal investigator for a number of federal grants, including the NIH Greater New York Autism Center of Excellence; the NIMH Research Training Grant in Psychopharmacology and Outcomes Research; the DOD CBDV in ASD treatment study; and FDA funded multicenter treatment trials of pediatric body dysmorphic disorder, autism and Prader Willi Syndrome. He was the principal investigator of the autism Clinical Trials
Network, and Chair of the eight centers NIH STAART Autism Steering Committee. He is involved in research on the neuropharmacology, neuropsychiatry, functional imaging, and treatment of obsessive-compulsive disorder, impulsive-aggressive disorders, obsessive-compulsive-related disorders such as body dysmorphic disorder, pathological gambling; Prader Willi Syndrome, and autism. Dr. Hollander served as Chair of the DSM-V Research Planning Agenda for Obsessive Compulsive Behavior Spectrum Disorders, and member of the DSM-5 Anxiety, Obsessive-Compulsive Spectrum, Post-Traumatic and Dissociative Disorders Workgroup, and the Behavioral and Substance Addictions Workgroup.
Dr. Hollander has received a Research Scientist Development Award from the National Institute of Mental health to investigate the psychobiology of obsessive-compulsive and related disorders. He has received orphan drug grants from the Food and Drug Administration to study new treatments for body dysmorphic disorder, child/adolescent autism, and adult autism, and a grant from the National Institute of Drug Abuse for a study on the neurobiology of pathological gambling. He has received several grants from the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke, to develop treatments for borderline personality disorder, adolescent body dysmorphic disorder, and autism; and a grant from the Department of Defense to study CBDV in autism spectrum disorder. Dr. Hollander has received two national research awards from the American Psychiatric Association and a Distinguished Investigator Award from the National Alliance for Research in Schizophrenia and Depression.
